Episode 60: Dutch™ Research And Validation In Peer-reviewed Journal Article

Episode 60: Dutch™ Research and Validation In Peer-Reviewed Journal Article

In today’s podcast, I chat with my friend and fellow laboratory geek Mark Newman, founder and president of Precision Analytical (creators of DUTCH), about his recent publication [Evaluating urinary estrogen and progesterone metabolites using dried filter paper samples and gas chromatography with tandem mass spectrometry (GC–MS/MS)], smartly published in an open access – and reputable – journal, BMC Chemistry, so it’s available to all, free of charge.

Episode 58: SPONSORED - Biocidin - Borrelia Research and Clinical Strategies using Botanical Antimicrobials

Episode 58: SPONSORED Biocidin – Borrelia Research and Clinical Strategies using Botanical Antimicrobials

Lyme disease (and co-infections) can be tough to treat. The Lyme spirochete, Borrelia burgdorferi, has adopted loads of devilishly clever cloaking devices – from thriving in biofilm to existing in pleomorphic forms – to ensure survival despite aggressive treatment. Enter botanical therapy. With or without concurrent antibiotics, botanical combinations are an essential component of the FxMed clinician’s toolkit.

Advances in Stool Testing: The GI-MAP™ GI-Microbial Assay Plus with Tony Hoffman

Episode 56: SPONSORED Advances in Stool Testing: The GI-MAP™ GI-Microbial Assay Plus with Tony Hoffman

I had loads of fun taking a tour through the wonderment of DSL GI MAP test today with Tony Hoffman, CEO of DSL (and longtime friend of mine!). DSL’s GI MAP stool test is, as CEO Tony Hoffman states, “a clinician diagnostic tool,” not a microbiome test. Yes, of course the GI MAP looks at the microbiome, but it’s not a broad sweep of the myriad bugs taking up residence.

Episode 54: SPONSORED Non-Alcoholic Fatty Liver Disease: Dr. Robert Rountree shares his Expertise (and Powerpoint!)

Non-alcoholic fatty liver disease is an urgent, often unrecognized concern. It’s the hepatic pandemic of the 21stcentury, and there is NO approved pharmaceutical therapy (the race is on, however…). Fortunately for us, there is MUCH we can do in functional medicine – indeed, our toolkit is powerfully effective in turning around NAFLD and even NASH – the next step progression.